Faster Answers, Better Decisions: ADLM 2026 Highlights
PRNewswire (Thu, 27-Aug 9:13 AM ET)
QuidelOrtho Lowers Full-Year Outlook—China Headwinds Drive Revenue Guidance Cut
Market Chameleon (Fri, 7-Aug 5:09 AM ET)
QuidelOrtho Reports Second Quarter 2026 Financial Results
PRNewswire (Thu, 6-Aug 4:06 PM ET)
QuidelOrtho to Report Second Quarter 2026 Financial Results
PRNewswire (Fri, 24-Jul 7:00 AM ET)
Beyond Fentanyl: How the Drug Crisis Is Changing
PRNewswire (Thu, 23-Jul 9:21 AM ET)
Business Wire (Thu, 23-Jul 7:00 AM ET)
QuidelOrtho Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PRNewswire (Wed, 15-Jul 7:32 PM ET)
QuidelOrtho Appoints Micah Young as Chief Financial Officer
PRNewswire (Tue, 23-Jun 7:12 AM ET)
PRNewswire (Tue, 2-Jun 7:12 AM ET)
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.
Quidelortho trades on the NASDAQ stock market under the symbol QDEL.
As of August 31, 2026, QDEL stock price declined to $14.43 with 841,103 million shares trading.
QDEL has a beta of 1.00, meaning it tends to be more sensitive to market movements. QDEL has a correlation of 0.02 to the broad based SPY ETF.
QDEL has a market cap of $982.42 million. This is considered a Small Cap stock.
Last quarter Quidelortho reported $631 million in Revenue and $.13 earnings per share. This beat revenue expectation by $9 million and exceeded earnings estimates by $.14.
In the last 3 years, QDEL traded as high as $84.60 and as low as $9.92.
The top ETF exchange traded funds that QDEL belongs to (by Net Assets): IJR, AVUV, VTI, VB, IWM.
QDEL has underperformed the market in the last year with a return of -48.5%, while SPY returned +19.4%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in QDEL shares. However, QDEL has outperformed the market in the last 3 month and 2 week periods, returning +10.4% and +0.9%, while SPY returned +1.9% and -1.2%, respectively. This indicates QDEL has been having a stronger performance recently.
QDEL support price is $14.01 and resistance is $15.48 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that QDEL shares will trade within this expected range on the day.